Eton Pharmaceutcials, Inc. Common Stock

ETONNASDAQUSD
38.66 USD
0.64 (1.69%)🟢PRE MARKET (AS OF 08:00 AM EDT)
🟢Market: OPEN

Eton Pharmaceutcials, Inc. Common Stock (ETON) trades at $38.66 per share. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Furthermore, ETON is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Jul 6, 2026.

Open?$38.03
High?$38.67
Low?$38.03
Prev. Close?$38.02
Volume?319
Avg. Volume?427.0K
VWAP?$38.30
Rel. Volume?0.00x
Bid / Ask
Bid?$32.70 × 100
Ask?$43.75 × 100
Spread?$11.05
Midpoint?$38.23
Valuation & Ratios
Market Cap?1.0B
Shares Out?27.4M
Float?24.3M
Float %?88.9%
P/E Ratio?N/A
P/B Ratio?34.02
EPS?-$0.05
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
Employees
44
Market Cap
1.0B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2018-11-14
Address
21925 W. FIELD PARKWAY
DEER PARK, IL 60010-7278
Phone: (847) 787-7361
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+2/3)
Medium-Term (Wave)? Bullish(+3/3)
Short-Term (Ripple)? Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
100
Momentum?
62
Short Sent.?
64
Piotroski F-Score?4/9Mixed
Altman Z-Score?8.79Safe
Confidence?59%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?5.86%Elevated
Short Interest?1.4M
Days to Cover?4.1
Free Float24.3M
Avg Daily Volume345.2K
Settlement Date2026-06-15
Financial Health
Current Ratio?1.21Adequate
Quick Ratio?0.88Weak
Cash Ratio?0.45Low
Debt/Equity?1.00Moderate
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score
33/100
P/E?
N/A
P/B?
Peers
100
S&P
3
34.02HIGH
P/S?
Peers
100
S&P
5
11.98HIGH
P/FCF?
Peers
100
S&P
6
67.5PRICEY
EV/EBITDA?
Peers
100
S&P
3
169.7HIGH
EV/Sales?
Peers
100
S&P
7
12.11HIGH
Returns & Efficiency
ROE?
S&P
11
-4.8%WEAK
ROA?
S&P
3
-1.5%WEAK
Cash Flow & Enterprise
FCF?$15.4M
Enterprise Value?$1.1B
Fundamentals ratios updated end of day